T2 Biosystems, Inc. Operating Lease Right-of-Use Assets
T2 Biosystems, Inc. had Operating Lease Right-of-Use Assets of $6.27 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-11-14
- 2024-09-30: Operating Lease, Right-of-Use Asset $6.27M.
- 2024-06-30: Operating Lease, Right-of-Use Asset $6.66M.
- 2024-03-31: Operating Lease, Right-of-Use Asset $7.03M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $7.39M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-09-30 | $6.27M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $6.66M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $7.03M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $7.39M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $7.75M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $8.09M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $8.42M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $8.74M 10-K · filed 2024-04-01 |
| 2022-09-30 | $9.06M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.17M 10-Q · filed 2022-08-16 |
| 2022-03-31 | $9.47M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $9.77M 10-K · filed 2023-03-31 |
| 2021-09-30 | $10.05M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $10.33M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.61M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $11.03M 10-K · filed 2022-03-23 |
| 2020-09-30 | $1.73M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.08M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $2.97M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.36M 10-K · filed 2021-03-31 |
| 2019-09-30 | $3.74M 10-Q · filed 2019-11-18 |
| 2019-06-30 | $4.11M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $4.46M 10-Q · filed 2019-05-10 |